No abstract available
MeSH terms
-
Anthracyclines / adverse effects
-
Anthracyclines / therapeutic use*
-
Antibiotics, Antineoplastic / adverse effects
-
Antibiotics, Antineoplastic / therapeutic use*
-
Biomarkers, Tumor / analysis*
-
Breast Neoplasms / chemistry
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / mortality
-
Breast Neoplasms / pathology
-
Chemotherapy, Adjuvant
-
Clinical Decision-Making
-
Female
-
Humans
-
Neoadjuvant Therapy* / adverse effects
-
Patient Selection
-
Quality of Life
-
Receptor, ErbB-2 / analysis*
-
Risk Assessment
-
Risk Factors
-
Treatment Outcome
Substances
-
Anthracyclines
-
Antibiotics, Antineoplastic
-
Biomarkers, Tumor
-
ERBB2 protein, human
-
Receptor, ErbB-2